BiRD (Biaxin [clarithromycin]/Revlimid [lenalidomide]/dexamethasone) combination therapy results in high complete- and overall-response rates in treatment-naive symptomatic multiple myeloma.
| Autor: | Niesvizky, Ruben, Jayabalan, David S., Christos, Paul J., Furst, Jessica R., Naib, Tara, Ely, Scott, Jalbrzikowski, Jessica, Pearse, Roger N., Zafar, Faiza, Pekle, Karen, LaRow, April, Lent, Richard, Mark, Tomer, Cho, Hearn J., Shore, Tsiporah, Tepler, Jeffrey, Harpel, John, Schuster, Michael W., Mathew, Susan, Leonard, John P., Mazumdar, Madhu, Chen-Kiang, Selina, Coleman, Morton |
|---|---|
| Zdroj: | In Blood 1 February 2008 111(3):1101-1109 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|